All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral | NCIT_C54299 | [A very rare ameloblastic carcinoma that originates from a pre-existing extraosseous benign ameloblastoma.] |
| LGI1 wt Allele | NCIT_C54290 | [Human LGI1 wild-type allele is located in the vicinity of 10q24 and is approximately 40 kb in length. This allele, which encodes leucine-rich glioma-inactivated protein 1, may be involved in both the regulation of the proliferation of various types of brain cells and neurotransmitter signal potentiation. Deletion of the wild type allele can result in autosomal dominant partial epilepsy with auditory features and the allele is expressed at reduced levels in brain tumors and malignant gliomas.] |
| LGI1 Gene | NCIT_C24548 | [This gene plays a role in neural cell function and is involved in the suppression of brain cancer.] |
| MUCL1 wt Allele | NCIT_C54291 | [Human MUCL1 wild-type allele is located in the vicinity of 12q and is approximately 4 kb in length. This allele, which encodes mucin-like protein 1, may be involved in the modulation of epithelial basement membrane structure. The expression of the gene may be a marker for metastatic breast cancer because it is expressed at elevated levels in breast carcinomas displaying lymph node metastases.] |
| Interventional Study Protocol Version Accepts Healthy Volunteers Indicator | NCIT_C93850 | [Specifies whether persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study.] |
| Interventional Study Protocol Version Allocation Code | NCIT_C93851 | [A coded value specifying the method of assigning subjects to treatment or control groups.] |
| Interventional Study Protocol Version Blinded Role Code | NCIT_C93852 | [A coded value specifying the roles of individuals who are masked for single or double blind studies.] |
| CDC73 wt Allele | NCIT_C54289 | [Human CDC73 wild-type allele is located in the vicinity of 1q25 and is approximately 132 kb in length. This allele, which encodes parafibromin protein, plays a role in the modulation of both RNA polymerase II-directed transcription and histone methylation. Hyperparathyroidism-jaw tumor syndrome is associated with mutations that result in truncation of this gene.] |
| CDC73 Gene | NCIT_C43569 | [This gene is involved in transcription and may play a role in cell cycle progression.] |
| Interventional Study Protocol Version Blinding Schema Code | NCIT_C93853 | [A coded value specifying the type of masking used on a study protocol to ensure that the results are not biased by the subjects or investigators.] |
| Interventional Study Protocol Version Control Concurrency Type Code | NCIT_C93854 | [A coded value specifying the temporal relationships of the control to the study intervention.] |
| Interventional Study Protocol Version Control Type Code | NCIT_C93855 | [A coded value specifying the kind of comparison or comparator against which the study treatment is evaluated.] |
| Interventional Study Protocol Version Intervention Group Quantity | NCIT_C93856 | [An integer specifying the number of intervention groups.] |
| Laboratory Identifier | NCIT_C93857 | [A unique symbol that establishes identity of the laboratory.] |
| Material Actual Indicator | NCIT_C93858 | [Specifies whether the material is real (actual) vs. placeholder (kind of).] |
| Material Description | NCIT_C93859 | [The textual representation of the material.] |
| Package Identifier Type Code | NCIT_C93890 | [A coded value specifying the kind of package identifier.] |
| Package Lot Number | NCIT_C93891 | [An alphanumeric string used to identify a particular batch of package.] |
| Package Name | NCIT_C93892 | [A non-unique textual identifier for the package.] |
| Package Type Code | NCIT_C93893 | [A coded value specifying the kind of package.] |